A consultation with European and international public health experts was convened to review data presented in newly conducted systematic reviews and meta-analyses regarding influenza antivirals, in order to develop an ECDC Expert Opinion.
In line with ECDC’s commitment to openness and transparency, and in order to receive comments from the scientific community and stakeholders, ECDC is launching a public consultation on the ‘Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza – review of recent systematic reviews and meta-analyses’.
How to submit contributions:
Comments should be submitted using this form* and sent to email@example.com.
Note that the comments received must clearly state the identity of the contributor (i.e. country, name and surname, and affiliation in the case of contributions from individuals; or name of organisation in the case of contributions on behalf of an organisation). Contributors are kindly asked to mention the respective line and page numbers of the document to which their comment(s) refer.
Please read the guidelines for submission of contributions and kindly note that only contributions following ECDC guidelines will be considered.
For more information on the processing of your personal data in the context of this consultation, read the specific privacy statement.
Deadline: 16 March 2016
*Users of Internet Explorer may encounter problems when opening this form. If you experience difficulties, please save the document as a compatible Word file before opening. To save, right click on the link and choose 'Save target as'.
If you are requested to provide a 'username' and 'password', click 'Cancel'. The form will open.